We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 10,000 results
  1. Suppression of cytokine release syndrome during CAR-T-cell therapy via a subcutaneously injected interleukin-6-adsorbing hydrogel

    The infusion of chimaeric antigen receptor (CAR) T cells can trigger the release of life-threatening supraphysiological levels of pro-inflammatory...

    **anlei Li, Ningqiang Gong, ... **ng-Jie Liang in Nature Biomedical Engineering
    Article 11 September 2023
  2. Functional CRISPR screens in T cells reveal new opportunities for cancer immunotherapies

    T cells are fundamental components in tumour immunity and cancer immunotherapies, which have made immense strides and revolutionized cancer treatment...

    Minghua **ang, Huayi Li, ... Yong Fang in Molecular Cancer
    Article Open access 05 April 2024
  3. CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models

    Background

    Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in childhood, whose prognosis is still poor especially for metastatic,...

    Andrea Timpanaro, Caroline Piccand, ... Michele Bernasconi in Journal of Experimental & Clinical Cancer Research
    Article Open access 04 November 2023
  4. Enhancing CAR-T cells: unleashing lasting impact potential with phytohemagglutinin activation in in vivo leukemia model

    Chimeric antigen receptor T (CAR-T) cell therapy holds great promise as an innovative immunotherapeutic approach for cancer treatment. To optimize...

    Berranur Sert, Gamze Gulden, ... Cihan Tastan in Cancer Gene Therapy
    Article 14 December 2023
  5. ThermomiR-377-3p-induced suppression of Cirbp expression is required for effective elimination of cancer cells and cancer stem-like cells by hyperthermia

    Background

    In recent years, the development of adjunctive therapeutic hyperthermia for cancer therapy has received considerable attention. However,...

    Tao-Yan Lin, Jun-Shuang Jia, ... Yan Sun in Journal of Experimental & Clinical Cancer Research
    Article Open access 29 February 2024
  6. Lithium carbonate revitalizes tumor-reactive CD8+ T cells by shunting lactic acid into mitochondria

    The steady flow of lactic acid (LA) from tumor cells to the extracellular space via the monocarboxylate transporter symport system suppresses...

    **gwei Ma, Liang Tang, ... Bo Huang in Nature Immunology
    Article Open access 23 January 2024
  7. A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression

    Here we report on the development and comprehensive evaluations of an mRNA vaccine for chronic hepatitis B (CHB) treatment. In two different HBV...

    Huajun Zhao, **anyu Shao, ... Yong Yang in npj Vaccines
    Article Open access 03 February 2024
  8. Antitumor progenitor exhausted CD8+ T cells are sustained by TCR engagement

    The durability of an antitumor immune response is mediated in part by the persistence of progenitor exhausted CD8 + T cells (Tpex). Tpex serve as a...

    **n Lan, Tian Mi, ... Ben Youngblood in Nature Immunology
    Article 30 May 2024
  9. Regulatory T cells in the face of the intestinal microbiota

    Regulatory T cells (T reg cells) are key players in ensuring a peaceful coexistence with microorganisms and food antigens at intestinal borders....

    Deepshika Ramanan, Alvin Pratama, ... Christophe Benoist in Nature Reviews Immunology
    Article 14 June 2023
  10. Control of the antitumour activity and specificity of CAR T cells via organic adapters covalently tethering the CAR to tumour cells

    On-target off-tumour toxicity limits the anticancer applicability of chimaeric antigen receptor (CAR) T cells. Here we show that the tumour-targeting...

    Alexey V. Stepanov, Jia **e, ... Richard A. Lerner in Nature Biomedical Engineering
    Article 05 October 2023
  11. Human T-cell lymphotropic virus type 1 (HTLV-1) grip on T-cells: investigating the viral tapestry of activation

    Introduction

    Human T-cell Lymphotropic virus type 1 (HTLV-1) belongs to retroviridae which is connected to two major diseases, including...

    Arash Letafati, Atefeh Bahavar, ... Sayed-Hamidreza Mozhgani in Infectious Agents and Cancer
    Article Open access 11 May 2024
  12. GPC3-targeted CAR-T cells expressing GLUT1 or AGK exhibit enhanced antitumor activity against hepatocellular carcinoma

    Chimeric antigen receptor-expressing T (CAR-T) cells induce robust antitumor responses in patients with hematologic malignancies. However, CAR-T...

    Rui-xin Sun, Yi-fan Liu, ... Zong-hai Li in Acta Pharmacologica Sinica
    Article 15 May 2024
  13. Helios expressing regulatory T cells are correlated with decreased IL-2 producing CD8 T cells and antibody diversity in Mozambican individuals living chronically with HIV-1

    Background

    Human immunodeficiency virus type 1 (HIV-1) causes impairment of T and B cell responses, which begins during the acute phase of infection...

    Raquel Matavele Chissumba, Cacildo Magul, ... Adam Yates in BMC Immunology
    Article Open access 14 March 2022
  14. Deciphering the importance of culture pH on CD22 CAR T-cells characteristics

    Background

    Chimeric antigen receptor (CAR) T-cells have demonstrated significant efficacy in targeting hematological malignancies, and their use...

    Michaela Prochazkova, Alexandra Dreyzin, ... ** ** in Journal of Translational Medicine
    Article Open access 24 April 2024
  15. CD20+ T cells: an emerging T cell subset in human pathology

    Introduction

    Although CD20 is classically a B cell marker, in the last three decades, dim expression has been noted on a subset of T cells as well...

    Adrian Y. S. Lee in Inflammation Research
    Article Open access 11 August 2022
  16. High-Dimensional Single-Cell Profiling of Tumor-Infiltrating CD4+ Regulatory T Cells

    CD4+ T regulatory cells (Tregs) are a specialized subset of T lymphocytes, which promote immune homeostasis and tumor immunosuppression by...
    Giorgia Alvisi, Simone Puccio, ... Enrico Lugli in Regulatory T-Cells
    Protocol 2023
  17. Isolation and Functional Characterization of Regulatory CD4+ T Cells from the Inflamed Joints of Patients with Rheumatoid Arthritis

    Regulatory T cellsRegulatory T cells (Tregs) play a critical role in maintaining immune homeostasis and in preventing and controlling unwanted immune...
    Giovanni A. M. Povoleri, Veerle Fleskens, Leonie S. Taams in Regulatory T-Cells
    Protocol 2023
  18. Targeted desialylation and cytolysis of tumour cells by fusing a sialidase to a bispecific T-cell engager

    Bispecific T-cell engagers (BiTEs) bring together tumour cells and cytotoxic T cells by binding to specific cell-surface tumour antigens and T-cell...

    Zhuo Yang, Yingqin Hou, ... Peng Wu in Nature Biomedical Engineering
    Article 01 May 2024
  19. Dynamics and specificities of T cells in cancer immunotherapy

    Recent advances in cancer immunotherapy — ranging from immune-checkpoint blockade therapy to adoptive cellular therapy and vaccines — have...

    Giacomo Oliveira, Catherine J. Wu in Nature Reviews Cancer
    Article 12 April 2023
  20. Targeted depletion of TRBV9+ T cells as immunotherapy in a patient with ankylosing spondylitis

    Autoimmunity is intrinsically driven by memory T and B cell clones inappropriately targeted at self-antigens. Selective depletion or suppression of...

    Olga V. Britanova, Kseniia R. Lupyr, ... Dmitry M. Chudakov in Nature Medicine
    Article Open access 23 October 2023
Did you find what you were looking for? Share feedback.